Clinical Trials Directory

Trials / Terminated

TerminatedNCT03521310

Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
91 (actual)
Sponsor
Björn Westrup, MD PhD · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The World Health Organization recommend all stable low birth weight neonates to have Skin-to-skin-Contact (SSC) after birth. Intermittent SSC is used in Sweden in neonatal units. Observations indicate that SSC makes neonates feel good. However, there is limited research done on SSC treatment on neonates born prior to week 33. The aim of this study is to investigate whether Skin-to-skin-Contact (SSC) leads to an improved physiological stabilization, altered epigenetic profile and improved longterm psychomotor outcome in neonates born in gestation age between week 28+0 - 32+6. This is a parallel, two-arm, multicentre, randomized controlled superiority trial. The two arms to be compared are a) immediate SSC with one parent/caregiver continous during the first 6 hours after birth and as much as possible during the first 72 hours, and b) conventional method of care during the same time.

Conditions

Interventions

TypeNameDescription
PROCEDURESkin-to-skinNeonates will get Skin-to-skin Contact with parent/caregiver continuously the first 6 hours after birth and as much as possible the first 72 hours after birth.
PROCEDUREConventional careNeonates will get Conventional care the first 72 hours after birth

Timeline

Start date
2018-04-01
Primary completion
2021-10-12
Completion
2021-10-12
First posted
2018-05-11
Last updated
2022-01-06

Locations

2 sites across 2 countries: Norway, Sweden

Source: ClinicalTrials.gov record NCT03521310. Inclusion in this directory is not an endorsement.